Rethinking antibody discovery in the age of automation
Drug Target Review
JUNE 19, 2025
This focus has allowed the company to serve not only large-scale industry users, but also academic groups and researchers in emerging markets who may otherwise lack access to advanced automation. James obtained his PhD in Analytical Chemistry from the University of Georgia. Still, barriers remain β particularly for smaller labs.
Let's personalize your content